GRANULES Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > granules

Technical Analysis

Technical Strength: 6.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 71.8. According to RSI analysis, granules is overbought. 3.0 GRANULES RSI Chart
MACD (?) MACD: 4.52 and Signal Line: 1.68. According to MACD analysis, granules is technically strong. 8.0 GRANULES MACD Chart
Simple Moving Average (?) 20-day simple moving average just got above it's 50-day simple moving average which is a positive signal. According to simple moving average analysis, granules is in a uptrend. Support level is at 132. 9.0 GRANULES Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, granules is in a uptrend. Support level is at 131. 9.0 GRANULES Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.92. According to bollinger bands, granules is technically strong. 7.0 GRANULES Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 132.7536 and 128.6. Resistance level is 146.2. 6.5 GRANULES Fibonacci Retracement Chart
Average True Range (?) ATR: 4.73 NA GRANULES Average True Range Chart
Average Directional Index (?) ADX is 27.4 which means GRANULES is in a trend. NA GRANULES Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 145.0
High Price 146.2
Low Price 142.05
Close Price 143.65
Absolute Change 1.15
Percentage Change 0.807%
Weekly Change 6.88%
Monthly Change 9.49%
Yearly Change 18.5%
52-week high 157.25
52-week low 91.45
Corporate Actions
ExDate Purpose
September 20, 2017 AGM/DIV-RE 0.25 PER SHARE
August 23, 2017 INT DIV-RE 0.25 PER SHARE
February 07, 2017 INT DIV RE 0.25 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.786
Confidence in Beta4.97%
Market Capital Rs. 2947.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 5.6
TTM Price-to-Earnings (P/E) Ratio 25.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:1.07e+06 NA GRANULES Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.4986 NA GRANULES Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 October 2017: PCR_OI:0.478 PCR:0.132 NA GRANULES PCR Chart
Option Pain (?) 19 October 2017: Max Pain:135.0 NA GRANULES Option Pain Chart
Premium (?) 19 October 2017 Premium: -0.7 Futures OI:15170000.0 NA GRANULES Premium Chart
Option_MAX_OI (?) 19 October 2017: Price:143.65 Put with maximum OI:135.0 Call with maximum OI:140.0 NA GRANULES Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 26, 2017 142.95 15170000.0 710.0 741.0 143.65
November 30, 2017 144.3 1325000.0 123.0 156.0 143.65
December 28, 2017 143.8 20000.0 1.0 1.0 143.65


October 18, 2017 GrUpdatesranules India Limited has informed the Exchange regarding 'Receipt of approval from US FDA for ANDA filed by USpharma Windlas, LLC'.
October 06, 2017 GrUpdatesranules India Limited has informed the Exchange regarding 'Receipt of Establishment Inspection Report (EIR) by Granules OmniChem facility from US FDA -Reg.'.
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 07, 2017 August 14, 2017 InResults/Dividendnter-alia, to consider and approve the Un-audited Financial Results for the first quarter ended June 30, 2017 and the payment of first interim dividend for the FY 2017-18, if any.
May 09, 2017 May 11, 2017 ThMeeting Updateshe following items shall be considered among other thing: 1. Raising funds by issue of equity shares by way of qualified institutions placement project to such approvals, as may be required, including approval of the shareholders of the Company; 2. Employee Stock Option Scheme 2017 to issue stock options to the employees of the Company and its subsidiaries. 3. A notice to the shareholders for convening General Meeting for approving, amongst other items, the aforementioned fund raise.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 137.6 Rs. 139.8 Rs. 141.7 Rs. 144 Rs. 145.9 Rs. 148.1 Rs. 150